Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China
· Delayed Price · Currency is CNY 3.570
0.00 (0.00%)
Apr 29, 2026, 3:04 PM CST
Shenzhen Glory Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 1,055 | 1,077 | 1,445 | 1,189 | 1,267 | 1,774 | Upgrade
|
| Other Revenue | - | - | 3.69 | 3.62 | 8.27 | 16.52 | Upgrade
|
| Revenue | 1,055 | 1,077 | 1,448 | 1,193 | 1,276 | 1,790 | Upgrade
|
| Revenue Growth (YoY) | -27.33% | -25.61% | 21.40% | -6.49% | -28.74% | -21.04% | Upgrade
|
| Cost of Revenue | 931.79 | 949.34 | 1,195 | 1,038 | 1,060 | 1,470 | Upgrade
|
| Gross Profit | 123.15 | 127.97 | 253.19 | 155 | 215.55 | 319.9 | Upgrade
|
| Selling, General & Admin | 143.83 | 145.63 | 145.27 | 153.23 | 157.94 | 170.75 | Upgrade
|
| Research & Development | 40.2 | 41.56 | 40.78 | 40.07 | 48.18 | 52.37 | Upgrade
|
| Other Operating Expenses | 21.62 | 22.5 | 22.27 | 19.96 | 18.24 | 22.4 | Upgrade
|
| Operating Expenses | 205.65 | 209.7 | 236.92 | 266.35 | 351.65 | 251.79 | Upgrade
|
| Operating Income | -82.5 | -81.73 | 16.27 | -111.34 | -136.1 | 68.11 | Upgrade
|
| Interest Expense | - | - | -5.83 | -2 | -4.44 | -7.22 | Upgrade
|
| Interest & Investment Income | 14.74 | 15.28 | 13.47 | 17.34 | 17.65 | 31.42 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 11.57 | 4.45 | -12.26 | -1.83 | Upgrade
|
| Other Non Operating Income (Expenses) | -105.49 | -80.02 | -3.02 | -2.5 | -60.37 | -16.87 | Upgrade
|
| EBT Excluding Unusual Items | -173.25 | -146.47 | 32.46 | -94.05 | -195.53 | 73.61 | Upgrade
|
| Impairment of Goodwill | - | - | - | -10.93 | -56.2 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.32 | 0.82 | 1.32 | -11.98 | -113.65 | 2.29 | Upgrade
|
| Gain (Loss) on Sale of Assets | 10.13 | 10.1 | 0.12 | -0.03 | - | -0.03 | Upgrade
|
| Asset Writedown | -22.04 | -22.04 | -3.2 | -3.01 | -16.86 | -1.23 | Upgrade
|
| Legal Settlements | - | - | -6.32 | -15.25 | -11.75 | -10.74 | Upgrade
|
| Other Unusual Items | - | - | 8.55 | 7.61 | 9.61 | 10.4 | Upgrade
|
| Pretax Income | -181.84 | -157.58 | 33.6 | -127.64 | -384.37 | 74.29 | Upgrade
|
| Income Tax Expense | -17.35 | -11.37 | 7.69 | 33.18 | -56.47 | 1.03 | Upgrade
|
| Earnings From Continuing Operations | -164.49 | -146.21 | 25.91 | -160.82 | -327.9 | 73.26 | Upgrade
|
| Minority Interest in Earnings | 9.14 | 6.63 | -3.63 | 11.93 | 19.84 | -28.73 | Upgrade
|
| Net Income | -155.35 | -139.58 | 22.28 | -148.89 | -308.06 | 44.52 | Upgrade
|
| Net Income to Common | -155.35 | -139.58 | 22.28 | -148.89 | -308.06 | 44.52 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -72.54% | Upgrade
|
| Shares Outstanding (Basic) | 825 | 821 | 844 | 845 | 845 | 831 | Upgrade
|
| Shares Outstanding (Diluted) | 825 | 872 | 884 | 845 | 845 | 870 | Upgrade
|
| Shares Change (YoY) | -10.60% | -1.34% | 4.64% | 0.03% | -2.86% | 3.89% | Upgrade
|
| EPS (Basic) | -0.19 | -0.17 | 0.03 | -0.18 | -0.36 | 0.05 | Upgrade
|
| EPS (Diluted) | -0.19 | -0.17 | 0.03 | -0.18 | -0.36 | 0.05 | Upgrade
|
| EPS Growth | - | - | - | - | - | -73.57% | Upgrade
|
| Free Cash Flow | -114.66 | 15 | 38.8 | -24.44 | 39.15 | -187.38 | Upgrade
|
| Free Cash Flow Per Share | -0.14 | 0.02 | 0.04 | -0.03 | 0.05 | -0.21 | Upgrade
|
| Dividend Per Share | - | - | 0.008 | - | - | - | Upgrade
|
| Gross Margin | 11.67% | 11.88% | 17.48% | 12.99% | 16.90% | 17.87% | Upgrade
|
| Operating Margin | -7.82% | -7.59% | 1.12% | -9.33% | -10.67% | 3.81% | Upgrade
|
| Profit Margin | -14.73% | -12.96% | 1.54% | -12.48% | -24.15% | 2.49% | Upgrade
|
| Free Cash Flow Margin | -10.87% | 1.39% | 2.68% | -2.05% | 3.07% | -10.47% | Upgrade
|
| EBITDA | 17.93 | 19.09 | 118.66 | -15.46 | -11.1 | 144.79 | Upgrade
|
| EBITDA Margin | 1.70% | 1.77% | 8.19% | -1.30% | -0.87% | 8.09% | Upgrade
|
| D&A For EBITDA | 100.43 | 100.82 | 102.39 | 95.88 | 125 | 76.68 | Upgrade
|
| EBIT | -82.5 | -81.73 | 16.27 | -111.34 | -136.1 | 68.11 | Upgrade
|
| EBIT Margin | -7.82% | -7.59% | 1.12% | -9.33% | -10.67% | 3.81% | Upgrade
|
| Effective Tax Rate | - | - | 22.89% | - | - | 1.39% | Upgrade
|
| Revenue as Reported | - | - | 1,448 | 1,193 | 1,276 | 1,790 | Upgrade
|
| Advertising Expenses | - | - | 0.75 | 1.66 | 0.37 | 0.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.